Clinical Trial Update: Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating sodium nitroprusside for blood pressure reduction in ICU patients. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Sodium nitroprusside (sodium nitroprusside)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Hypertension | Phase 2 | Status: COMPLETED